AlphaYouLP
Schedule 13G filing
Leviticus Partners LP disclosed a 5.2% stake in Harvard Bioscience Inc (HBIO)
Leviticus Partners LP reported owning 5.2% of Harvard Bioscience Inc (HBIO) (235,000 shares) in a Schedule 13G filed Sep 22, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.